Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Week Liechtenstein.
Press releases published on April 14, 2025
Swarm Joins Hivello—Marking the 10th DePIN Network Aggregated
GlobeNewswire
·
April 14, 2025
LONDON and AMSTERDAM, April 14, 2025 (GLOBE NEWSWIRE) -- Hivello, a DePIN aggregator that enables users to earn by monetizing idle computer resources across multiple DePINs (Decentralized Physical Infrastructure Networks), has officially integrated Swarm …
Qorvo® Announces Results of Board Refreshment Process
GlobeNewswire
·
April 14, 2025
Appoints Richard L. Clemmer and Christopher R. Koopmans as Independent Directors David H. Y. Ho to Retire from the Board GREENSBORO, N.C., April 14, 2025 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq:QRVO), a leading global provider of connectivity and power …
Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 14, 2025
CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
GlobeNewswire
·
April 14, 2025
XOMA Royalty sold the remaining Kinnate pipeline assets for a total of up to $270 million in upfront and milestone payments, plus royalties on commercial sales at rates ranging from low single digits to mid-teens Holders of Kinnate Contingent Value Rights …
Avicanna Reports Full Year 2024 Audited Financial Statement
GlobeNewswire
·
April 14, 2025
2024 Revenue of $25.5M, a 52% increase from 2023 Consolidated Gross Margins of 51%, Gross Profits of $12.9M, a 94% increase from 2023 TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: …
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
GlobeNewswire
·
April 14, 2025
DUBLIN, Ireland and OXFORD, United Kingdom, April 14, 2025 (GLOBE NEWSWIRE) -- SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that …
Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer
GlobeNewswire
·
April 14, 2025
Mr. Salus Brings More than 30 Years of Broad-Based Legal and Management Expertise Highlighted by Extensive Experience within Life Sciences Industry Significantly Elevates Lifecore’s Capabilities Across Corporate Governance, Transactional Activities, and …
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
GlobeNewswire
·
April 14, 2025
LEIDEN, Netherlands …
Soleno Therapeutics Announces VYKAT(TM) XR Launch
GlobeNewswire
·
April 14, 2025
REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the U.S. commercial availability of …
Skye Bioscience to Conduct Meetings at Piper Sandler Conference
GlobeNewswire
·
April 14, 2025
SAN DIEGO, April 14, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that its …
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
GlobeNewswire
·
April 14, 2025
Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June 5, 2025 Initial distribution expected in the range between approximately $246.6 million …
Signing Day Sports Signs Non-Binding Letter of Intent to Acquire All Equity of blockchAIn Digital Infrastructure, a Profitable Data Hosting Company
GlobeNewswire
·
April 14, 2025
blockchAIn Digital Infrastructure Generated Unaudited Revenue of $26.8 million and Net Income of $4.0 million in 2024 blockchAIn Digital Infrastructure Focused on Crypto Mining, Artificial Intelligence (“AI”), and High-Performance Computing (“HPC”) Data …
Synaptics Unveils Next-Generation Touch Controller Engineered for Foldable OLED Displays
GlobeNewswire
·
April 14, 2025
SAN JOSE, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its S3930 series breakthrough touch controllers purpose-built to meet the unique technical challenges and high-performance demands of foldable OLED …
Offshoring solutions provider Yempo to run 2025 Australia roadshow
GlobeNewswire
·
April 14, 2025
SYDNEY, April 14, 2025 (GLOBE NEWSWIRE) -- From 12 May to 10 June, industry-leading specialist offshoring solutions company Yempo will be running its 2025 roadshow in Australia, where its story began 11 years ago. Yempo is a specialist provider of …
Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
GlobeNewswire
·
April 14, 2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel®* for US patients with disabling inflammatory diseases Despite FDA approval nearly a decade …
Digital Assault Ai Officially Launches, Delivering Enterprise-Grade Marketing Tools and Reseller Access in One Affordable Platform
GlobeNewswire
·
April 14, 2025
BOISE, ID, April 13, 2025 (GLOBE NEWSWIRE) -- A new era in digital marketing accessibility begins today with the national launch of DIGITAL ASSAULT AI, a comprehensive SaaS platform that combines the power of Vendasta and GoHighLevel into one unified, …